MegakaryocytesMegakaryocyte Progenitor CellsThrombopoietinHematopoietic Stem Cell TransplantationHematopoietic Stem CellsStem Cell TransplantationStem CellsBone Marrow CellsThrombopoiesisTransplantation, HomologousTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation ConditioningAntigens, CD34HematopoiesisColony-Forming Units AssayCell DifferentiationGraft vs Host DiseaseReceptors, ThrombopoietinStem Cell FactorBone Marrow TransplantationInterleukin-3ThrombocytopeniaHematologic NeoplasmsLiver TransplantationCells, CulturedBone MarrowMesenchymal Stem Cell TransplantationTransplantation ChimeraPloidiesEmbryonic Stem CellsBlood PlateletsAdult Stem CellsGraft SurvivalCord Blood Stem Cell TransplantationTreatment OutcomeCell LineageTissue DonorsCell TransplantationNeural Stem CellsHematopoietic Stem Cell MobilizationKidney TransplantationMyeloablative AgonistsErythropoietinWhole-Body IrradiationGranulocyte-Macrophage Colony-Stimulating FactorBusulfanCell DivisionMultiple MyelomaMultipotent Stem CellsRecombinant ProteinsRecurrenceHistocompatibility TestingCombined Modality TherapyTime FactorsMelphalanRemission InductionStem Cell NicheMesenchymal Stromal CellsGranulocyte Colony-Stimulating FactorCell ProliferationRetrospective StudiesImmunosuppressive AgentsFlow CytometryMice, Inbred C57BLHistocompatibilityLeukemiaPluripotent Stem CellsPlatelet CountGraft vs Leukemia EffectHeart TransplantationCell SeparationMyeloid Progenitor CellsFetal BloodCyclophosphamideTransplantation ImmunologyDisease-Free SurvivalFetal Stem CellsLung TransplantationVidarabineSurvival RateLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisInduced Pluripotent Stem CellsGraft RejectionRegenerationHepatic Veno-Occlusive DiseaseSalvage TherapyChimerismCell Culture TechniquesCell CountOrgan TransplantationTransplantation, IsogeneicHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntigens, CDGraft vs Tumor EffectMyelodysplastic SyndromesHLA Antigens